"Pergolide" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A long-acting dopamine agonist which has been used to treat PARKINSON DISEASE and HYPERPROLACTINEMIA but withdrawn from some markets due to potential for HEART VALVE DISEASES.
| Descriptor ID |
D010479
|
| MeSH Number(s) |
D03.132.327.287.800 D03.633.400.439.800
|
| Concept/Terms |
LY-127809- LY-127809
- LY127809
- LY-127,809
- LY127,809
|
Below are MeSH descriptors whose meaning is more general than "Pergolide".
Below are MeSH descriptors whose meaning is more specific than "Pergolide".
This graph shows the total number of publications written about "Pergolide" by people in this website by year, and whether "Pergolide" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pergolide" by people in Profiles.
-
Pergolide is an inhibitor of voltage-gated potassium channels, including Kv1.5, and causes pulmonary vasoconstriction. Circulation. 2005 Sep 06; 112(10):1494-9.
-
Pleuropulmonary disease due to pergolide use for restless legs syndrome. Chest. 2001 Jul; 120(1):313-6.
-
The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease. Mov Disord. 1999 Nov; 14(6):940-6.
-
Pergolide and bromocriptine for the treatment of patients with hyperprolactinemia. Am J Obstet Gynecol. 1986 Feb; 154(2):431-5.
-
Dystonia-Parkinson syndrome: differential effects of levodopa and dopamine agonists. Clin Neuropharmacol. 1986; 9(3):298-302.